Cargando…
New Drugs and Therapies in Pulmonary Arterial Hypertension
Pulmonary arterial hypertension is a chronic, progressive disorder of the pulmonary vasculature with associated pulmonary and cardiac remodeling. PAH was a uniformly fatal disease until the late 1970s, but with the advent of targeted therapies, the life expectancy of patients with PAH has now consid...
Autores principales: | Shah, Aangi J., Beckmann, Taylor, Vorla, Mounica, Kalra, Dinesh K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058689/ https://www.ncbi.nlm.nih.gov/pubmed/36982922 http://dx.doi.org/10.3390/ijms24065850 |
Ejemplares similares
-
Molecular Pathways in Pulmonary Arterial Hypertension
por: Shah, Aangi J., et al.
Publicado: (2022) -
Strategizing Drug Therapies in Pulmonary Hypertension for Improved Outcomes
por: Beckmann, Taylor, et al.
Publicado: (2022) -
Role of Lipid-Lowering Therapy in Peripheral Artery Disease
por: Belur, Agastya D., et al.
Publicado: (2022) -
Myocarditis associated with COVID-19 and its vaccines - a systematic review
por: Rout, Amit, et al.
Publicado: (2022) -
A Rapidly Growing Cardiac Mass—Malignant or Benign?
por: Rout, Amit, et al.
Publicado: (2023)